|
See related Kogenate FS powd for inj information |
|
|
|
Manufacturer |
Bayer HealthCare Pharma |
|
Distributor |
DKSH |
|
Contents |
Recombinant antihemophilic factor VIII |
|
Indications |
Treatment of hemophilia A & prophylaxis of bleeding. Prophylaxis of ped patients to reduce the occurrence of spontaneous hemorrhagic episodes in hemophilia A & to significantly reduce the risk of joint damage compared to episodic treatment. |
|
Dosage |
Individualized dosage. The in vivo % elevation in FVIII level can be estimated by multiplying the dose per kg of body wt (IU/kg) by 2%. |
|
Special Precautions |
Hypersensitivity to mouse or hamster protein. Pregnancy, lactation. |
|
Adverse Drug Reactions |
Infusion site reactions, rash, pruritus, urticaria, pyrexia, anaphylactic reaction.
View ADR Monitoring Form |
|
Drug Interactions |
Other coagulation proteins.
View more drug interactions with Kogenate FS |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Kogenate FS powder for injection |
|
Kogenate FS (set w/ vial adapter) 250 IU x 1's |
|
Kogenate FS (set w/ vial adapter) 500 IU x 1's |
|
|
|
Manufacturer: |
Bayer HealthCare Pharma |
|
Distributor: |
DKSH
|
|
|
|
